Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Care

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.23.6.779PMID 10840996
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.

  2000cited by this paper
• Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

  1999cited by this paper
• The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

  1999cited by this paper
• Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians.

  1999cited by this paper
• Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus

  1999cited by this paper
• Plasma acylation stimulating protein, adipsin and lipids in non‐obese and obese populations

  1999cited by this paper
• Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice.

  1999cited by this paper
• Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity.

  1998cited by this paper
• Adipose tissue as an endocrine and paracrine organ

  1998cited by this paper
• Relationship between serum C3 levels and traditional risk factors for myocardial infarction.

  1998cited by this paper
• Is Type II diabetes mellitus a disease of the innate immune system?

  1998cited by this paper
• The adipsin-acylation-stimulating protein pathway and microenvironmental metabolic regulation.

  1997cited by this paper
• ASP stimulates glucose transport in cultured human adipocytes

  1997cited by this paper
• NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

  1997cited by this paper
• Plasma acylation-stimulating protein in coronary artery disease.

  1997cited by this paper
• Acute in vitro production of acylation stimulating protein in differentiated human adipocytes.

  1997cited by this paper
• Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line.

  1997cited by this paper
• Serum complement and familial combined hyperlipidemia.

  1997cited by this paper
• Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity

  1997cited by this paper
• Additive effect of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis.

  1996cited by this paper
• Immunological mechanisms in atherosclerosis

  1995cited by this paper
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

  1995cited by this paper
• Use of dual-energy X-ray absorptiometry in obese individuals.

  1995cited by this paper
• Association of serum C3 levels with the risk of myocardial infarction.

  1995cited by this paper
• [Immunological mechanisms in atherosclerosis].

  1994cited by this paper
• Immune mechanisms in atherosclerosis.

  1994cited by this paper
• Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link

  1994cited by this paper
• Synthesis of complement components in liver and at extrahepatic sites

  1993cited by this paper
• Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein.

  1993cited by this paper
• Plasma C3d Levels and Ischemic Heart Disease in Type II Diabetes

  1993cited by this paper
• Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes

  1992cited by this paper
• Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes.

  1992cited by this paper
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

  1991cited by this paper
• Levels of acylation stimulating protein in obese women before and after moderate weight loss.

  1991cited by this paper
• Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.

  1990cited by this paper
• Immune mechanisms in atherosclerosis.

  1989cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Complement biosynthesis in vitro by rat hepatoma cell strains.

  1975cited by this paper

• Complement at the crossroads of inflammation and metabolism: implications for diabetes and metabolic functions.

  2025cites this paper
• Beta-cell-specific C3 deficiency exacerbates metabolic dysregulation and insulin resistance in obesity

  2025cites this paper
• Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients With Rheumatoid Arthritis

  2024cites this paper
• Impact of Uncontrolled Diabetes Mellitus on Blood Cells Indices and Plasma Components in Patients Without Nephropathy.

  2023cites this paper
• Diabetes, Diabetic Retinopathy, and Inflammatory Disorders

  2023cites this paper
• Reprogramming astrocytic NDRG2/NF-κB/C3 signaling restores the diabetes-associated cognitive dysfunction

  2023cites this paper
• Effect of Cow-Calf Supplementation on Gene Expression, Processes, and Pathways Related to Adipogenesis and Lipogenesis in Longissimus thoracis Muscle of F1 Angus × Nellore Cattle at Weaning

  2023cites this paper
• Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus

  2022cites this paper
• Components of the Complement Cascade Differ in Polycystic Ovary Syndrome

  2022cites this paper
• Cross talk between complete blood count and progression of type II diabetes mellitus

  2021cites this paper
• Medical Records-Based Genetic Studies of the Complement System

  2021cites this paper
• Maternal serum proteomic profiles of pregnant women with type 1 diabetes

  2021cites this paper
• Inflammation in Metabolic and Cardiovascular Disorders—Role of Oxidative Stress

  2021cites this paper
• Immune Function Response Following a Low-carbohydrate, High-fat Diet (LCHFD) in Patients with Type 2 Diabetes

  2021cites this paper
• Dietary intake of bioactive ingredients impacts liver and adipose tissue transcriptomes in a porcine model of prepubertal early obesity

  2020cites this paper
• Prevalence of leukocytes in type 2 diabetic patients in Erbil City

  2020cites this paper
• Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus

  2020cites this paper
• EVALUATION OF C3 COMPLEMENT AND INFLAMMATORY MARKER (C-REACTIVE PROTEIN) IN TYPE 2 DIABETES SUBJECTS WITH INSULIN RESISTANCE

  2019cites this paper
• Relationships of Complement Components C3 and C4 and their Genetics to Cardiometabolic Risk in Healthy, Non-Hispanic White Adolescents

  2019cites this paper
• Association between Complement System, Inflammatory Cytokines and Glucose Control in Obese Subjects

  2018cites this paper
• Complement Factor C3 Methylation and mRNA Expression Is Associated to BMI and Insulin Resistance in Obesity

  2018cites this paper
• Associations of immunological factors with metabolic syndrome and its characteristic elements in Chinese centenarians

  2018cites this paper
• Inquisition of Variations in Serum Protein Profile Induced by Fat Rich Diet in Rattus norvegicus

  2018cites this paper
• The complement system is dysfunctional in metabolic disease: Evidences in plasma and adipose tissue from obese and insulin resistant subjects.

  2017cites this paper
• Complement 3 serum levels as a pro-inflammatory biomarker for insulin resistance in obesity.

  2017cites this paper
• Inflammation and insulin resistance according to body composition in European adolescents: the HELENA study.

  2017cites this paper
• Screening for potential serum‐based proteomic biomarkers for human type 2 diabetes mellitus using MALDI‐TOF MS

  2017cites this paper
• An increase level of acylation stimulating protein is correlated with metabolic risk markers in North Indian obese women.

  2017cites this paper
• Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes

  2017cites this paper
• Clinical significance of serum complement factor 3 in patients with type 2 diabetes mellitus.

  2017cites this paper
• Effects of single or combined induction of diabetes mellitus and knee osteoarthritis on some biochemical and haematological parameters in rats.

  2017cites this paper
• Alkylglycerols reduce serum complement and plasma vascular endothelial growth factor in obese individuals

  2016cites this paper
• Effect of Obesity and Associated Disorders like Diabetes, Dyslipidemia & Hypertension on Levels of Serum Complement Component C3 in Indian Ethnic Population

  2016cites this paper
• Identification of C1q as a Binding Protein for Advanced Glycation End Products.

  2016cites this paper
• Complement component C3: relationship with obesity, insulin resistance and cardiovascular risk markers.

  2015cites this paper
• Summary and future perspectives for oral insulin delivery

  2015cites this paper
• Plasma complement C3 levels are associated with insulin secretion independently of adiposity measures in non-diabetic individuals.

  2015cites this paper
• Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Mellitus Over a 7-Year Follow-up Period: The CODAM Study

  2014cites this paper
• The complement system in human cardiometabolic disease.

  2014influential citation
• Levels of acylation stimulating protein and the complement component 3 precursor are associated with the occurrence and development of coronary heart disease

  2014cites this paper
• Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study

  2014cites this paper
• Detection level of urea, sugar, creatinine and hematology in patients of diabetic mellitus type II

  2014cites this paper
• Novel aspects of insulin resistance and type 2 diabetes mellitus: iron metabolism, the complement system, and liver cirrhosis

  2014cites this paper
• Extraglomerular C3 deposition and metabolic impacts in patients with IgA nephropathy.

  2013cites this paper
• C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling

  2013cites this paper
• Activated complement factor 3 is associated with liver fat and liver enzymes: the CODAM study

  2013cites this paper
• Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy.

  2013cites this paper
• Molecular Bases of Disease

  2013cites this paper
• Gender dimorphism in regulation of plasma proteins in streptozotocin‐induced diabetic rats

  2013cites this paper
• Mice Lacking C1q Are Protected from High Fat Diet-induced Hepatic Insulin Resistance and Impaired Glucose Homeostasis*

  2013cites this paper
• Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study.

  2012cites this paper
• Triacylglycerols and body fat mass are possible independent predictors of C3 in apparently healthy young Brazilian adults.

  2012cites this paper
• Serum complement C3 predicts renal arteriolosclerosis in non-diabetic chronic kidney disease.

  2012cites this paper
• The metabolic syndrome and cardiovascular disease: the CODAM study

  2011cites this paper
• Alteration of antioxidant defense status precedes humoral immune response abnormalities in macrosomia

  2011cites this paper
• Surrogate markers of insulin resistance: A review.

  2010cites this paper
• Metabolic impact on serum levels of complement component 3 in Japanese patients

  2010cites this paper
• Peranan Kadar C3 dan C4 pada Penderita Diabetes Mellitus

  2010influential citation
• Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese

  2010cites this paper
• Causes of the Oral therapy secondary failure in patients with Diabetes mellitus type 2

  2009cites this paper
• Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance

  2009cites this paper
• The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation

  2009cites this paper
• Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.

  2009cites this paper
• Change in plasma acylation stimulating protein during euglycaemic‐hyperinsulinaemic clamp in overweight and obese postmenopausal women: a MONET study

  2009cites this paper
• University of Warwick institutional repository: http://go

  2008cites this paper
• Immune System Response to Aerobic Exercise Training in Obese Females

  2008cites this paper
• Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease

  2008cites this paper
• The Plasma Adiponectin Levels in Patients with Newly Diagnosed Type 2 Diabetes.

  2007cites this paper
• Chylomicron accelerates C3 tick‐over by regulating the role of Factor H, leading to overproduction of acylation stimulating protein

  2007cites this paper
• Serum C3 Is a Stronger Inflammatory Marker of Insulin Resistance Than C-Reactive Protein, Leukocyte Count, and Erythrocyte Sedimentation Rate

  2007cites this paper
• Hostility, anger, and depression predict increases in C3 over a 10-year period.

  2007cites this paper
• Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study

  2007cites this paper
• Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings.

  2007cites this paper
• SERUM LEVELS OF ADIPONECTIN IN NON-DIABETIC AND DIABETIC OBESE INDIVIDUALS

  2007cites this paper
• Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors

  2007cites this paper
• Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study

  2007cites this paper
• Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin

  2006cites this paper
• Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes

  2006cites this paper
• Association of Serum Adiponectin Concentration to Lipid and Glucose Metabolism in Healthy Humans

  2006cites this paper
• Adipose tissue metabolism, diabetes and vascular disease — lessons from in vivo studies

  2006cites this paper
• Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study.

  2006cites this paper
• Increased Acylation Stimulating Protein Concentrations in Nonalcoholic Fatty Liver Disease are Associated with Insulin Resistance

  2005cites this paper
• Chronic Inflammatory Hypothesis in the Metabolic Syndrome

  2005cites this paper
• Complement C 3 Is a Risk Factor for the Development of Diabetes A Population-Based Cohort Study

  2005cites this paper
• The reciprocal association of adipocytokines with insulin resistance and C-reactive protein in clinically healthy men.

  2005cites this paper
• Plasma Adiponectin and Insulin Resistance in Korean Type 2 Diabetes Mellitus

  2005cites this paper
• Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction.

  2005cites this paper
• Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects

  2005cites this paper
• In vivo evidence of impaired peripheral fatty acid trapping in patients with human immunodeficiency virus-associated lipodystrophy.

  2005cites this paper
• The evolving role of inflammation in obesity and the metabolic syndrome

  2005cites this paper
• Perspectives in Diabetes A Burning Question Does an Adipokine-Induced Activation of the Immune System Mediate the Effect of Overnutrition on Type 2 Diabetes ?

  2005cites this paper
• Regulation of Complement C3 Expression by the Bile Acid Receptor FXR*

  2005cites this paper
• Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study

  2005cites this paper
• Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes

  2005cites this paper
• A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?

  2005cites this paper
• Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.

  2005cites this paper
• Metabolic dysregulation and interventions in type 2 diabetes mellitus and HIV-lipodystrophy

  2005cites this paper
• Molecular, endocrine, and genetic mechanisms of arterial calcification.

  2004cites this paper
• Die Leukozytenzahl als Prädiktor für Glukosetoleranz und Insulinsensitivität

  2004cites this paper
• Microarray gene expression profiling in obesity and insulin resistance.

  2004cites this paper